Kinney Horn Olema Pharmaceuticals, Inc. (OLMA) insider trading activity

Kinney Horn is Chief Business Officer of Olema Pharmaceuticals, Inc.. Currently has a direct ownership of 2,458 shares of OLMA, which is worth approximately $12,216. The most recent transaction as insider was on Mar 10, 2022, when has been sold 5,253 shares (Common Stock) at a price of $4.75 per share, resulting in proceeds of $24,952. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.46K

0% 3M change

0% 12M change

Total Value Held $12,216

Kinney Horn Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 10 2022	SELL Open market or private sale	$24,952 $4.75 p/Share	5,253 Reduced 68.12%	2,458 Common Stock
Mar 10 2022	BUY Exercise of conversion of derivative security	$10,821 $2.06 p/Share	5,253 Added 40.52%	7,711 Common Stock
Feb 10 2022	SELL Sale (or disposition) back to the issuer	-	5,251 Reduced 68.12%	2,458 Common Stock
Feb 10 2022	BUY Exercise of conversion of derivative security	$10,817 $2.06 p/Share	5,251 Added 40.52%	7,709 Common Stock
Jan 10 2022	SELL Open market or private sale	$35,969 $6.85 p/Share	5,251 Reduced 68.12%	2,458 Common Stock
Jan 10 2022	BUY Exercise of conversion of derivative security	$10,817 $2.06 p/Share	5,251 Added 40.52%	7,709 Common Stock
Dec 10 2021	SELL Open market or private sale	$54,558 $10.39 p/Share	5,251 Reduced 68.12%	2,458 Common Stock
Dec 10 2021	BUY Exercise of conversion of derivative security	$10,817 $2.06 p/Share	5,251 Added 40.52%	7,709 Common Stock
Nov 10 2021	SELL Open market or private sale	$743,716 $26.88 p/Share	27,668 Reduced 93.92%	1,790 Common Stock
Nov 10 2021	BUY Exercise of conversion of derivative security	$291,344 $10.53 p/Share	27,668 Added 48.43%	29,458 Common Stock
Oct 11 2021	SELL Open market or private sale	$146,135 $27.83 p/Share	5,251 Reduced 74.58%	1,790 Common Stock
Oct 11 2021	BUY Exercise of conversion of derivative security	$10,817 $2.06 p/Share	5,251 Added 42.72%	7,041 Common Stock
Sep 10 2021	SELL Open market or private sale	$154,274 $29.38 p/Share	5,251 Reduced 74.58%	1,790 Common Stock
Sep 10 2021	BUY Exercise of conversion of derivative security	$10,817 $2.06 p/Share	5,251 Added 42.72%	7,041 Common Stock
Aug 10 2021	SELL Open market or private sale	$136,211 $25.94 p/Share	5,251 Reduced 74.58%	1,790 Common Stock
Aug 10 2021	BUY Exercise of conversion of derivative security	$10,817 $2.06 p/Share	5,251 Added 42.72%	7,041 Common Stock
Jul 12 2021	SELL Open market or private sale	$140,044 $26.67 p/Share	5,251 Reduced 74.58%	1,790 Common Stock
Jul 12 2021	BUY Exercise of conversion of derivative security	$10,817 $2.06 p/Share	5,251 Added 42.72%	7,041 Common Stock
Jun 10 2021	SELL Open market or private sale	$153,802 $29.29 p/Share	5,251 Reduced 74.58%	1,790 Common Stock
Jun 10 2021	BUY Exercise of conversion of derivative security	$10,817 $2.06 p/Share	5,251 Added 42.72%	7,041 Common Stock
May 18 2021	SELL Open market or private sale	$1,410,572 $24.42 p/Share	57,763 Reduced 96.99%	1,790 Common Stock
May 18 2021	BUY Exercise of conversion of derivative security	$118,992 $2.06 p/Share	57,763 Added 49.24%	59,553 Common Stock

Also insider at

IMNM

Immunome Inc. Healthcare

CHIEF BUSINESS OFFICER

Kinney Horn

Chief Business Officer

San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OLMA shares.

Notify only if

Value

Insider Trading

Get notified when an Olema Pharmaceuticals, Inc. insider buys or sells OLMA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Olema Pharmaceuticals, Inc.

Track Activities on OLMA

Account